794
Views
19
CrossRef citations to date
0
Altmetric
ARTICLES

Barriers to Clinical Trial Participation: Comparing Perceptions and Knowledge of African American and White South Carolinians

, , , &

References

  • Advani, A. S., Atkeson, B., Brown, C. L., Peterson, B. L., Fish, L, Johnson, J. L. & Gautier, M. (2003). Barriers to the participation of African-American Patients with cancer in clinical trials: A pilot study. Cancer, 97, 1499–1506.
  • Ard, J. D., Durant, R. W., Edwards, L. C. & Svetkey, L. P. (2005). Perceptions of African-American culture and implications for clinical trial design. Ethnicity & Disease, 15, 292–299.
  • Association of Clinical Research Professionals. (2009, April). CenterWatch 2008 National Survey of Study Volunteer Experiences. Paper presented at the 2009 Association of Clinical Research Professionals Global Conference & Exhibition, Denver, Colorado.
  • Baquet, C. R., Commiskey, P., Mullins, D. & Mishra, S. I. (2006). Recruitment and participation in clinical trials: Sociodemographic, rural/urban, and health care access predictors. Cancer Detection and Prevention, 30, 24–33.
  • Braunstein, J. B., Sherber, N. S., Schulman, S. P., Ding, E. L. & Powe, N. R. (2008). Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine, 87, 1–9.
  • Brown, D. R., Fouad, M. N., Basen-Engquist, K. & Tortolero-Luna, G. (2000). Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Annals of Epidemiology, 10, S13–21.
  • Byrne, M. M., Tannenbaum, S. L., Gluck, S., Hurley, J. & Antoni, M. (2014). Participation in cancer clinical trials: Why are patients not participating? Medical Decision Making, 34, 116–126.
  • Christian, M. C. & Trimble, E. L. (2003). Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomark Prevention, 12, 277s–283s.
  • Cohen, G. I. (2003). Clinical research by community oncologists. CA: A Cancer Journal for Clinicians, 53, 73–81.
  • Comis, R. L., Miller, J. D., Aldigé, C. R., Krebs, L. & Stoval, E. (2003). Public attitudes toward participation in cancer clinical trials. Journal of Clinical Oncology, 21, 830–835.
  • Cottler, L. B., McCloskey, D. J., Aguilar-Gaxiola, S., Bennett, N. M., Strelnick, H., Dwyer-White, M. & Evanoff, B. (2013). Community needs, concerns, and perceptions about health research: Findings from the clinical and translational science award sentinel network. American Journal of Public Health, 103, 1685–1692.
  • Ding, E. L., Powe, N. R., Manson, J. E., Sherber, N. S. & Braunstein, J. B. (2007). Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: A randomized study of cardiovascular prevention trials. Archives of Internal Medicine, 167, 905–112.
  • Du, W., Mood, D., Gadgeel, S. & Simon, M. S. (2008). An educational video to increase clinical trials enrollment among lung cancer patients. Journal of Thoracic Oncology, 3, 23–29.
  • Dunlap, W. P. & Kemery, E. R. (1987). Failure to detect moderating effect: Is multicollinearity the problem? Psychological Bulletin, 102, 418–420.
  • Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C. & Bass, E. B. (2007). Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer, 112, 228–242.
  • Frank, G. (2004). Current challenges in clinical trial patient recruitment and enrollment. SoCRA Source, 2, 30–38.
  • Friedman, D. B., Bergeron, C. D., Foster, C., Tanner, A. & Kim, S.-H. (2013). What do people really know and think about clinical trials? A comparison of rural and urban communities in the South. Journal of Community Health, 38, 642–651.
  • Friedman, D. B., Corwin, S. J., Rose, I. D. & Dominick, G. M. (2009). Prostate cancer communication strategies recommended by older African-American men in South Carolina: A qualitative analysis. Journal of Cancer Education, 24, 204–209.
  • Getz, K. A. (2008). Restoring public confidence in clinical research: Lessons from the organ donation sector. The Monitor, 2008, 59–62.
  • Ghanem, S. (1997). Filling in the tapestry: The second level of agenda setting. In M. McCombs D. L. Shaw & D. Weaver (Eds.), Communication and democracy (pp. 3–14). Hillsdale, NJ: Erlbaum.
  • Giuliano, A. R., Mokuau, N., Hughes, C., Tortolero-Luna, G., Risendal, B., Ho, R. C. S. & McCaskill-Stevens, W. J. (2000). Participation of minorities in cancer research: The influence of structural, cultural, and linguistic factors. Annals of Epidemiology, 10, S22–S34.
  • Guadagnolo, B. A., Petereit, D. G., Helbig, P., Koop, D., Kussman, P., Dunn, E. F. & Patnaik, A. (2009). Involving American Indians and medically underserved rural populations in cancer clinical trials. Clinical Trials, 6, 610–617.
  • Harris Interactive. (2001). Misconceptions and lack of awareness greatly reduce recruitment for cancer clinical trials. Retrieved from http://www.harrisinteractive.com/about/vert_healthcare
  • Harris, Y., Gorelick, P. B., Samuels, P. & Bempong, I. (1996). Why African Americans may not be participating in clinical trials. Journal of the National Medical Association, 88, 630–634.
  • Jackson, J. S., Knight, K. M. & Rafferty, J. A. (2010). Race and unhealthy behaviors: Chronic stress, the HPA axis, and physical and mental health disparities over the life course. American Journal of Public Health, 100, 933–939.
  • Jones, J. M., Nyhof-Young, J., Moric, J., Friedman, A., Wells, W. & Catton, P. (2006). Identifying motivations and barriers to patient participation in clinical trials. Journal of Cancer Education, 21, 237–242.
  • Katz, R. V., Russell, S. L., Kressin, N. R., Green, B. L., Wang, M. Q, James, S. A. & Claudio, C. (2006). The Tuskegee Legacy Project: Willingness of minorities to participate in biomedical research. Journal of Healthcare for Poor and Underserved, 17, 698–715.
  • Kelch, R. P. (2002). Maintaining the public trust in clinical research. New England Journal of Medicine, 346, 285–287.
  • Lara, P. N., Jr., Higdon, R., Lim, N., Kwan, K., Tanaka, M., Lau, D. H. M. & Lam, K. S. (2001). Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. Journal of Clinical Oncology, 19, 1728–1733.
  • Lara, P. N. Jr., Paterniti, D. A., Chiechi, C., Turrell, C., Morain, C., Horan, N. & Chen, M. S., Jr. (2005). Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. Journal of Clinical Oncology, 23, 9282–9289.
  • Moinpour, C. M., Atkinson, J. O., Thomas, S. M., Underwood, S. M., Harvey, C., Parzuchowski, J. & Coltman, C. A., Jr. (2000). Minority recruitment in the prostate cancer prevention trial. Annals of Epidemiology, 10(8 Suppl.), S85–S91.
  • Owens, O. L., Jackson, D. D., Thomas, T. L., Friedman, D. B. & Hebert, J. R. (2013). African American men's and women's perceptions of clinical trials research: Focusing on prostate cancer among a high risk population in the South. Journal of Health Care for the Poor and Underserved, 24, 1784–1800.
  • Quinn, G. P., Bell, B. A., Bell, M. Y., Caraway, V. D., Conforte, D., Graci, L. B. & Bepler, G. (2007). The guinea pig syndrome: Improving clinical trial participation among thoracic patients. Journal of Thoracic Oncology, 2, 191–196.
  • Sateren, W. B., Trimble, E. L., Abrams, J., Brawley, O., Breen, N., Ford, L. & Christian, M. C. (2002). How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. Journal of Clinical Oncology, 20, 2109–2117.
  • Shavers, V. L., Lynch, C. F. & Burmeister, L. F. (2002). Racial differences in factors that influence the willingness to participate in medical research studies. Annals of Epidemiology, 12, 248–256.
  • Steeh, C. & Piekarski, L. (2008). Accommodating new technologies: Mobile and VoIP communication. In J. M. Lepkowski C. Tucker J. M. Brick E. D. De Leeuw L. Japec P. J. Lavrakas … R. L. Sangster (Eds.), Advances in telephone survey methodology (pp. 423–448). New York, NY: Wiley.
  • Stiller, C. (1994). Centralized treatment, entry to trials, and survival. British Journal of Cancer, 70, 352–362.
  • Tanner, A., Kim, S.-H., Friedman, D. B., Foster, C. & Bergeron, C. (2015). Barriers to medical research participation as perceived by clinical trial investigators: Reaching out to rural and African American communities in South Carolina. Journal of Health Communication, 20, 88–96.
  • U.S. Census Bureau. (2010). State and county quick facts. Retrieved from http://quickfacts.census.gov/qfd/states/45000.html
  • Zhang, Q., Wang, Y. & Huang, E. S. (2009). Changes in racial/ethnic disparities in the prevalence of type 2 diabetes by obesity level among US adults. Ethnicity & Health, 14, 439–457.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.